Skip to main content
Fig. 2 | Critical Care

Fig. 2

From: Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial

Fig. 2

Time-to-event curves for the primary endpoint, death, and resuscitated cardiac arrest in the early resuscitation period. a Primary composite outcome, b all-cause mortality, and c death or resuscitated cardiac arrest within the first 48-h of initiation of inotropic therapy. Survival curves were constructed using Kaplan–Meier estimates. Adjusted relative risk using Chi-square testing was used for the primary outcome including age, sex, beta-blocker use, type of inotrope, and history of atrial fibrillation as covariates. Unadjusted relative risks using Chi-square testing was used for all-cause mortality and death or resuscitated cardiac arrest

Back to article page

Critical Care

ISSN: 1364-8535